In addition, meta-analyses of human cancers have shown that PPAT is most strongly associated with malignancy among the metabolic enzymes, particularly prominent in neuroendocrine cancers, including small cell lung cancer (SCLC) (170). This evidence concerns the gene PPAT and small cell lung carcinoma.